Many zoo elephants do not cycle normally, and for African elephants, it is often associated with hyperprolactinemia. Dopamine agonists successfully treat hyperprolactinemia-induced ovarian dysfunction in women, but not elephants. The objective of this study was to determine how longitudinal dopamine, serotonin, and oxytocin patterns in African elephants are related to ovarian cycle function. We hypothesized that dopamine concentrations are decreased, while oxytocin and serotonin are increased in non-cycling, hyperprolactinemic African elephants. Weekly urine and serum samples were collected for eight consecutive months from 28 female African elephants. Females were categorized as follows: (1) non-cycling with average prolactin concentrations of 15 ng/ml or greater (HIGH; n = 7); (2) non-cycling with average prolactin concentrations below 15 ng/ml (LOW; n = 13); and (3) cycling with normal progestagen and prolactin patterns (CYCLING; n = 8). Both oxytocin and serotonin were elevated in hyperprolactinemic elephants. Thus, we propose that stimulatory factors may play a role in the observed hyperprolactinemia in this species. Interestingly, rather than being reduced as hypothesized, urinary dopamine was elevated in hyperprolactinemic elephants compared to CYCLING and LOW prolactin groups. Despite its apparent lack of regulatory control over prolactin, this new evidence suggests that dopamine synthesis and secretion are not impaired in these elephants, and perhaps are augmented.
Introduction
Successful reproduction of captive African elephants is important as they are an integral part of conservation and education outreach programs at many institutions and serve as ambassadors for wild counterparts experiencing precipitous declines [1, 2] . Regrettably, zoo elephant populations are not self-sustaining and are facing a demographic bottleneck as older females age and pass out of the population. It is estimated that six to nine offspring are needed annually to maintain an adequate population size [3] . However, in a recent demographic analysis of the North American population, only about 26% of African elephant females had produced a calf, resulting in just 77 calves born over a 40-year period (1970-2010) , and reflecting an average of 1.93 births per year during that time [4] . A high priority is then to ensure all reproductively viable females have an opportunity to breed, either through natural mating or the use of artificial insemination. A concern for population sustainability is that many female elephants of reproductive age do not exhibit normal ovarian cycles [5] [6] [7] . In a 2012 survey, 57% of African elephant females in North America were acyclic [7] .
Normal ovarian function relies on temporal secretory patterns of pituitary and gonadal hormones, including prolactin, which increases during the nonluteal phase of the African elephant estrous cycle, and is likely involved in normal follicular development [6, 8] , as it is in other mammalian species. By contrast, hyperprolactinemia, or excess prolactin production, negatively impacts health and reproduction in several species. It also occurs in elephants and was first discovered in 1997 [9] , and later confirmed in subsequent studies [6, 10] . Hyperprolactinemia is always associated with ovarian acyclicity and hypogonadism in women [11] [12] [13] , as well as in African elephants [6, 8, 10] . Interestingly, cyclic prolactin secretion during the ovarian cycle is not observed in Asian elephant females, nor is hyperprolactinemia a problem [6, 8, 10] . In African elephants, it is postulated that high prolactin suppresses gonadotropins, while low prolactin production is insufficient to support normal follicular function [8] . In the same 2012 survey, 48% (28/58) of acyclic African elephants exhibited hyperprolactinemia, while the remaining elephants fell into the low prolactin category (30/58, 52%) [7] .
In a recent study, Brown et al. [7] found that female African elephants that spent time in a larger number of different social groups had a greater chance of being hyperprolactinemic, suggesting that not being in a stable social group may be a stressor that elicits a prolactin response. This could indicate that hyperprolactinemic elephants over compensate to maintain social bonds with unrelated herd mates by increasing prolactin production, a hormone known to be associated with pair bonding [14] [15] [16] [17] , but which can occur at the expense of reproduction [18] .
Prolactin is a polypeptide secreted by the lactotroph cells of the anterior pituitary gland [19, 20] . Originally named for its role in stimulating milk synthesis, it is now understood to be a pleiotropic neurohormone with over 300 neuroendocrine functions (e.g. stimulation of maternal behavior, regulation of appetite and body weight, suppression of fertility, control of neurogenesis and glial cell function) [19, 20] . Additionally, prolactin plays a homeostatic role through regulation of the immune system, osmotic balance, angiogenesis, and the stress response [19, 20] . Thus, besides the negative effects of prolactin on reproductive function, prolonged alteration in prolactin secretion can have significant negative consequences on overall health and quality of life [21] . Although both hyper and low prolactin production are thought to be contributing to low reproductive rates in female African elephants [8] , hyperprolactinemia is of great concern because it may be impacting overall health and well-being in zoo elephants.
Lactotrophs (prolactin secreting cells) are unique among anterior pituitary cell populations in that they spontaneously secrete their hormone product, so in the absence of inhibitory signals, prolactin is secreted at a high rate [19, 22] . Prolactin secretion is predominantly under inhibitory control via the hypothalamic tuberoinfundibular system (TIDA) [19, 22] . Dopamine, a highly conserved monoamine, is a powerful inhibitor of prolactin release more so than other catecholamines such as norepinephrine [19, 22, 23] . Indeed, studies have shown that dopamine concentrations are reduced in women with idiopathic hyperprolactinemia, currently making dopamine agonists the most common treatment for this condition and associated ovarian dysfunction [11, 24, 25] . In particular, the dopamine agonist, cabergoline, is a common and effective treatment for hyperprolactinemia-induced infertility in women [13, 26, 27] . However, clinical trials in African elephants that examined the efficacy of cabergoline to reinitiate ovarian cycles (n = 9) did not show similar results [28, 29] . Although prolactin was decreased significantly in all but one female, none resumed cycling. Prolactin concentrations then rebounded to or exceeded initial levels within weeks of treatment withdrawal. Thus, the question of how prolactin is regulated in elephants and whether it is comparable to the mechanisms known for other species warranted further investigation.
Although prolactin release is mainly influenced by hypothalamic dopamine inhibition, stimulatory factors also play a role in finetuning prolactin secretion in response to physiological (i.e. pregnancy, suckling) or environmental (i.e. light-dark cycles, stress) changes [22] . Evidence suggests that oxytocin, one of the oldest neuromodulators in the animal world, may be a major prolactinreleasing factor [30, 31] , and aid in stimulation of prolactin surges during proestrous or in response to suckling [30, 31] . Furthermore, human and animal studies have shown that there is a positive feedback mechanism between prolactin and oxytocin, and concentrations of oxytocin are known to increase in hyperprolactinemia [32, 33] .
Serotonin also stimulates prolactin release from hypothalamic neurons that emanate from the raphe nucleus, and its actions are mediated via a number of serotonin receptors [34] . Its stimulatory role is compounded by increasing the release of other prolactin-releasing factors, such as thyrotropin-releasing hormone and vasoactive intestinal peptide [22] . Correspondingly, serotonin concentrations are increased in hyperprolactinemic patients and animal models [33, 35, 36] . Although no longer a common treatment, serotonin antagonists have been used to reduce prolactin concentration in hyperprolactinemic subjects [33, 35, 36] .
Patterns of dopamine, oxytocin, or serotonin concentrations have not been investigated in normal cycling or hyperprolactinemic elephants. In model species, neuromodulators are generally measured centrally (i.e. pituitary portal system, cerebrospinal fluid), but this is not feasible in elephants. Peripheral and excreted measurements of these biomarkers, however, can be used to assess perturbations of the nervous system [37, 38] . In Asian elephants, urinary dopamine was measured using high-performance liquid chromatography and shown to increase near ovulation [39] . Understanding if neurohormones play regulatory roles in elephants could help us design better treatments to mitigate the negative consequences of long-term hyperprolactinemia. The objective of this study was to describe longitudinal dopamine, serotonin, and oxytocin secretion in African elephants non-invasively in urine. We hypothesized that secretory patterns are altered in hyperprolactinemic elephants as compared to normal cycling controls: specifically, that dopamine is decreased, and oxytocin and serotonin are increased in elephant females that are producing excessive amounts of prolactin.
Materials and methods

Ethics statement
This study was approved by management at each participating zoo and, where applicable, was reviewed and approved by zoo research committees. In addition, the study received AZA endorsement, and was approved by the Smithsonian National Zoological Park's ACUC (#13-36).
Assay validations
Neurohormones are known to rapidly degrade in biological fluids after collection, so a pilot study was conducted in collaboration with the Maryland Zoo in Baltimore to identify an optimal preservation method. Weekly urine and serum samples were collected for one complete estrous cycle (16 weeks) from a normal cycling African elephant female, and each matched sample was treated with one of three preservatives: 4 mM sodium metabisulfite (SMBS), 0.6 TIU aprotinin, and 0.1% ascorbic acid (v/v). Control samples with no preservative were also collected. Results showed that samples preserved with ascorbic acid (vitamin C) diluted to a final concentration of 0.1% (v/v) consistently demonstrated high immunoreactivity for all three neurohormones (dopamine, serotonin, and oxytocin) (supplemental data). Additionally, unlike the other preservatives (SMBS and aprotinin), ascorbic acid could be shipped, handled, and stored with minimal safety concerns for both personnel and elephants at participating zoological institutions. Therefore, ascorbic acid was selected as the preservative for all subsequent sample collections and studies.
To validate each enzyme immunoassay (EIA), parallelism was demonstrated between serial dilutions of pooled samples with the respective standard curves (Figure 1a -c). We also demonstrated significant recovery (>85% and <115%) of standard hormone added to serum or urine before analysis, showing there was no matrix interference. The only exception was preserved serum in the dopamine assay, where there was no cross-reactivity ( Figure 1a ). Analysis of dopamine, serotonin, oxytocin, and prolactin concentrations in the 16-week samples found patterns similar to other species [13, 19, 22, 33] . Namely, a weak negative correlation between urinary dopamine and serum prolactin (r 2 = -0.38, P = 0.01), a weak positive correlation between urinary serotonin and serum prolactin (r 2 = 0.33, P = 0.02), and a strong positive serum oxytocin and serum prolactin (r 2 = 0.89, P = 0.02) were observed. Thus, preliminary data indicated these immunoassays measured biologically relevant analytes, and that these neurohormones may function to modulate prolactin in elephants like that in other species.
Study animals and sample collection
Matched serum and urine samples (approximately 3 ml each) were collected weekly for 8 months from 28 female elephants at 11 participating zoos (896 total samples). An overview of the study population is provided in Table 1 . Blood was drawn from either the caudal aspect of the ear or the saphenous vein in the leg. All elephants were conditioned to the blood sampling procedure, which was part of the weekly management routine. Blood for progestagen and prolactin analyses was maintained at 4 • C, centrifuged at the facility within an hour of collection, and stored frozen at −20 • C or colder. For neurohormone samples, participating facilities were sent urine and serum collection tubes prefilled with ascorbic acid, which were stored at 4 • C until use (up to 3 months). Weekly urine was collected either free catch or off the enclosure floor using a syringe immediately after urination. Urine tubes contained 250 μl of 1% ascorbic acid solution. Urine was added to the 2.5-ml line on chilled tubes, bringing the final dilution of the preservative to 0.1% (v/v) and frozen within 1 h of collection. Weekly blood was collected directly into chilled 3-ml serum separator tubes containing 150 μl of 2% ascorbic acid, bringing the final dilution of preservative to 0.1% (v/v). Preserved blood samples were centrifuged and frozen within 1 h of collection. Both preserved urine and serum were stored at −20 • C or colder. Samples were shipped on dry ice to the SCBI and stored at −20 • C until analysis.
Hormone analyses
A double-antibody EIA was utilized to measure serum progestagens. Briefly, a secondary goat anti-mouse antibody (Cat. No. A008, Arbor Assays, Ann Arbor, MI) was diluted (10 μg/ml) in coating buffer (Cat. No. X108, 20X, Arbor Assays) and added to each well (150 μl) of a 96-well microtiter plate (Cat. No. 07-200-39, Fisher Scientific, Pittsburgh, PA), followed by incubation at room temperature (RT) for 15-24 h. The contents of the wells were emptied, the plates were then blotted dry, and blocking solution (Cat. No. X109, 10X, Arbor Assays) was added to each well (250 μl) and incubated for 15-24 h at RT. Following incubation, the contents of the wells were emptied; the plates were then blotted and dried at RT in a Dry Keeper (Sanplatecorp. Osaka, Japan) with loose desiccant in the bottom. After drying (humidity <20%), plates were heat sealed in a foil bag with a 1 g desiccant packet and stored at 4 • C until use. An anti-progesterone monoclonal primary antibody (CL425; C. J. Munro, UC Davis, CA) and progesterone-3CMO-horseradish peroxidase (HRP) were used to measure progestagen concentrations in the serum samples. Before use, a pre-coated goat anti-mouse IgG plate was allowed to come to RT (approximately30 min). The CL425 antibody and HRP were diluted in assay buffer (Cat. No. X065, 5X, Arbor Assays) to 1:50 000 and 1:110 000, respectively, and kept at 4 • C until use. Standards (Steraloids, Inc., Newport, Rhode Island), internal controls and neat samples (50 μl each) were added to each well in duplicate, followed by addition of 25 μl HRP, and then 25 μl of primary antibody (except for nonspecific binding wells). The assays were incubated at RT for 2 h with shaking (500 rpm) before being washed 5 times with wash solution (Cat. No. X007, 20X, Arbor Assays) and blotted dry. High kinetic tetramethylbenzidine (TMB) (2.5 mmol/L, Prod. No. TMB-HK, Moss, Inc.; 100 μl) was added as the chromagen substrate to all wells. The assays were covered and incubated at RT without shaking for 30 min and then stopped with 50 μl of 1 N HCL. Plates were read immediately at 450 nm. The assay sensitivity (based on 90% maximum binding) was 0.02 ng/ml; intra-assay and inter-assay coefficients of variation were <10% (20 assays).
Highly purified ovine prolactin (NIDDK-oPRL) was iodinated using chloramine-T, and followed the same procedures described in [9] . Serum prolactin was measured in duplicate by heterologous RIA validated for elephants [9, 40] , which uses an anti-human prolactin antiserum (NIDDKanti-hPRL-3) and ovine prolactin label and standards (NIDDKoPRL-I-2). The assay was conducted using a phosphatebuffered saline-bovine serum albumin (BSA) buffer system (0.01 M PO 4 , 0.5% BSA, 2 mM ethylenediaminetetraacetic acid, 0.9% NaCl, and 0.01% thimerosal, pH 7.6), with the exception of the goat anti-rabbit second antibody where BSA was omitted. The assay sensitivity was 0.16 ng/ml. Serum samples exceeding the top standard of 80 ng/ml were diluted 1:5 and analyzed again. Intra-assay and interassay coefficients of variation were <10% (22 assays).
The EIAs for dopamine (Dopamine Research ELISA BA E-5300, Rocky Mountain Diagnostics, Inc.), oxytocin (Oxytocin ELISA, ADI-901-153, Enzo Life Sciences), and serotonin (Serotonin Research ELISA BA E-5900, Rocky Mountain Diagnostics, Inc.) were developed for use with a variety of sample types (cerebrospinal fluid, serum, urine, milk, saliva) and validated for multiple species (humans, rodents, nonhuman primates, etc., per company literature). Standards provided in each kit that bound at 30% and 70% were selected as controls and run on each assay. Samples were analyzed in duplicate following kit instructions for each neurohormone. Preserved urine was used to measure dopamine, oxytocin, and serotonin across all study groups (n = 28 elephants). Preserved serum was used to analyze oxytocin and serotonin in cycling elephants only (n = 8) to compare with urinary concentrations. Preserved urine and serum samples were diluted between 1:8 and 1: 32 for dopamine, 1:4 and 1: 16 for oxytocin, and 1:375 and 1:1500 for serotonin in the buffers provided in each kit. The complete sample set for each study elephant (32 samples/elephant) was analyzed for all three neurohormones on the same day to minimize sample freeze thaw cycles. The assay sensitivities were 0.5, 0.0156, and 0.02 ng/ml for dopamine, oxytocin, and serotonin, respectively. The interassay coefficients of variation were <10% for each neurohormone (32 assays).
To measure oxytocin from preserved serum, samples were extracted following the protocol provided by Enzo Life Sciences. Briefly, an equal volume of 0.1% triflouroacetic acid (TFA) in water was added to 300-500 μl of preserved serum and centrifuged at 170 00 g for 15 min at 4 • C to clarify the sample, and the supernatant was saved. A 200 mg C18 Sep-Pak column was equilibrated with 1 ml of acetonitrile, followed by 25 ml of 0.1% TFA. The supernatant was then applied to the Sep-Pak column and washed with 10 ml of 0.1% TFA. The sample was eluted slowly (gravity-fed) into plastic tubes by applying 3 ml of a solution comprised of 95% acetonitrile and 5% of 0.1% TFA. The extracts were evaporated in a lyophilizer and stored at −20 • C until analyses. Three plate's worth of samples were reconstituted at a time (complete sample sets from three elephants) with 300-500 μl of assay buffer provided in the kit, briefly sonicated, and analyzed in duplicate within 1 h. Preserved serum did not require extraction for serotonin analyses.
Urine was analyzed for creatinine (Crt) using a colorimetric assay to account for individual fluid volume differences. Samples were diluted between 1:10 and 1:40 with dilution buffer (0.2M NaH 2 PO 4 , 0.2M Na 2 HPO 4 , 0.2M NaCl, pH 7.0), and 100 μl was analyzed in duplicate 96-well flat bottom microtiter plates. A 1:1 alkaline picrate reagent (100 μl 0.04M picric acid: 0.75N NaOH) was added to all samples and standards (Sigma Chemical Co., St. Louis, MO), and incubated for 30 min at RT. Absorption was read at 490 nm. Results were expressed as mass of steroid/mg Crt.
Determination of ovarian cyclicity and prolactin status
Ovarian cyclicity status was determined based on serum progestagen levels [6, 41, 42] . First, baseline values were calculated for each individual using an iterative process whereby all progestagen values above the mean plus 1.5 times the standard deviation (SD) were removed and the process repeated until no values exceeding the mean + 1.5 * SD remained [40, 41, 43, 44] . The remaining data points defined the baseline for that individual. Data were used to categorize the cyclicity status of each elephant as follows: normal cycling (regular 13-to 17-week progestagen cycles, n = 8) ( Figure 2 ); or acyclic (baseline progestagens < 0.1 ng/ml, throughout, n = 20) [45] (Figure 3) .
Acyclic females were further categorized into two abnormal prolactin status groups based on prolactin secretion that lacked a typical temporal pattern (Figure 2) , and average prolactin concentrations that were higher or lower than a cutoff value for the 8-month collection period [7, 8] . The cut-off value was determined using ROC curve analyses and the concordance statistic [46, 47] , and determined to be 15 ng/ml (AUC = 0.959, 95% CI 0.919 to 0.999). For statistical analyses, noncycling elephants with an average prolactin concentration of 15 ng/ml or greater were considered HIGH (n = 7), while noncycling elephants with average prolactin concentrations below 15 ng/ml were considered LOW (n = 13). Elephants with normal temporal patterns of both progestagen (i.e. cycling) and prolactin were considered CYCLING (n = 8).
Data analyses
Hormone data are presented as the mean ± SEM. For urinary dopamine, oxytocin, and serotonin, peak and baseline concentrations were determined for each individual by the iterative process described above [40, 41, 43, 44] . The highest concentration within a group of elevated samples was considered a peak, and baseline values were those remaining after all high values had been excluded. To determine if there were differences associated with hyperprolactinemia, differences in neurohormone concentrations (overall, baseline, and peak means) across the groups (i.e. CYCLING, HIGH, and LOW) were determined using a multivariate generalized linear model followed by an LSD post hoc test. Neurohormone data were log transformed on the natural scale to meet the model assumptions. No outliers significantly affected the results or assumptions, so the full log-transformed data set was used.
Results
Age did not differ across the study groups or impact ovarian cyclicity or prolactin status. For cycling females (Figure 2a ), the average length of the estrous cycle was 105.5 ± 3.8 days (range 69-149 days), with a luteal phase length of 67.5 ± 3.6 days (range 38 117 days) and a follicular phase of 40.0 ± 3.1 days (range 13-85 days). Prolactin secretion was variable with no distinguishable pattern in the HIGH and LOW prolactin groups. Concentrations in the LOW prolactin group remained at relatively stable baseline levels (Figure 2b ), but differed from the clear temporal profile observed in cycling females, where elevations were observed during the follicular phase (Figure 2a ).
Overall mean prolactin values differed among the study groups, with overall concentrations in the HIGH prolactin noncycling ele-phants being more than four times those of normal cycling females (P = 0.004) ( Table 2 ). Overall prolactin concentrations were significantly different between the LOW and HIGH prolactin groups, with concentrations being about six times higher in the HIGH prolactin group (P = 0.001). Baseline values differed among the study groups, with concentrations in the noncycling hyperprolactinemic elephants being more than five times those of normal cycling elephants (P = 0.01) and more than six times those of LOW prolactin elephants (P = 0.004). Baseline concentrations of noncycling LOW prolactin group were not different from those of normal cycling elephants (P = 0.743). Peak values differed among the study groups, with concentrations in the non-cycling HIGH prolactin group being about five times higher than those in CYCLING (P = 0.001) and LOW prolactin (P < 0.001) groups. Two elephants exhibited prolactin concentrations exceeding 100 ng/ml, with the highest concentration measured at 174 ng/ml. Figure 3a illustrates secretory profiles of urinary dopamine for representative noncycling females categorized as LOW or HIGH prolactin elephants. Overall mean concentrations in noncycling LOW prolactin elephants did not differ from CYCLING females that showed clear elevations in concentrations during the luteal phase of the cycle when prolactin concentrations were at their lowest ( Figure 3b ) (P = 0.84). Compared to CYCLING elephants, baseline mean (P = 0.065) and peak mean (P = 0.51) dopamine Data include the number of elephants that were included in each variable (n), and overall, baseline, and peak mean including, SEM, minimum, and maximum, for serum prolactin (ng/mL), and urinary dopamine (ng/mg Crt), oxytocin (pg/mg Crt), and serotonin (ng/mg Crt). a,b,c Indicates significant differences between groups. * Significant at the 0.05 probability level. * * Significant at the 0.01 probability level. concentrations in the LOW category were not significantly different.
Urinary dopamine
Hyperprolactinemic elephants had overall urinary dopamine concentrations that were more than twice those found in CYCLING (P = 0.028) and LOW prolactin elephants (P = 0.013) ( Table 2) . Baseline urinary dopamine concentrations in HIGH elephants were more than double those observed in the CYCLING prolactin group (P = 0.045), but were not different from LOW prolactin elephants, although they did approach significance (P = 0.065). High prolactin elephants had higher peak mean concentrations that were more than twice those concentrations found in LOW prolactin (P = 0.007) and CYCLING (P = 0.007). Urinary dopamine concentrations consistently peaked close to 200 ng/mg Crt in HIGH prolactin elephants, with the highest recorded at 450 ng/mg Crt in two elephants.
Urinary dopamine was negatively correlated with serum PRL concentrations in all CYCLING elephants (n = 8). Concentrations ranged from 1.01 ng/mg Crt at their lowest point, and in two elephants, concentrations peaked over 100 ng/mg Crt, with the highest concentration measured at 207.94 ng/mg Crt in one elephant. Figure 4a illustrates secretory profiles of urinary oxytocin for representative noncycling females categorized as LOW or HIGH prolactin elephants. Secretion was variable with no distinguishable pattern, and occasionally reached baseline in noncycling LOW prolactin elephants. Overall (P = 0.43), baseline (P = 0.25) and peak (P = 0.64) concentrations did not differ between the LOW and CYCLING prolactin groups. Concentrations in noncycling LOW prolactin elephants differed from CYCLING prolactin females that showed a clear elevation in concentrations during the follicular phase when prolactin concentrations were at their highest (Figure 4b ).
Urinary oxytocin
Hyperprolactinemic elephants had overall mean concentrations that were 1.3 times higher compared to concentrations found in LOW (P = 0.008) and CYCLING (P = 0.005) prolactin elephants ( Table 2 ). There was no difference between HIGH and CYCLING prolactin elephants in baseline (P = 0.92) or peak (0.073) concentrations, although peak mean did approach significance, with the highest concentration measured at 25.4 ng/mg Crt in one HIGH prolactin elephant.
Urinary oxytocin was positively correlated with serum prolactin concentrations in all cycling normal prolactin elephants (n = 8). In CYCLING elephants, urinary oxytocin concentrations ranged from 0.26 ng/mg Crt at the lowest point, with peak concentrations reaching 4.16 ng/mg Crt in one elephant. Figure 5a illustrates secretory profiles of urinary serotonin for representative noncycling females categorized as LOW or HIGH prolactin elephants. Overall serotonin mean did not differ from CYCLING elephants (P = 0.48), but was about half that observed in HIGH prolactin (P = 0.012) elephants ( Table 2) . Concentrations in noncycling LOW prolactin elephants also differed from cycling normal prolactin females that showed a clear elevation in concentrations during the follicular phase when prolactin concentrations were at their highest (Figure 5b ).
Urinary serotonin
Hyperprolactinemic elephants had overall mean urinary serotonin concentrations that were about twice those found in LOW prolactin elephants ( Table 2) , which approached significance (P = 0.09). Baseline urinary serotonin concentrations in hyperprolactinemic elephants were more than twice those observed in the LOW prolactin group (P = 0.008), and nearly differed significantly from CY-CLING prolactin elephants (P = 0.052). There were no differences in peak mean concentrations between the HIGH and CYCLING (P = 0.07) prolactin groups, though again, concentrations were nearly significant. Peak mean concentrations were 1.6 times higher in HIGH prolactin elephants compared to the LOW prolactin study group (P = 0.04), with the highest peak concentration measured at 548.21 ng/mg Crt in one HIGH prolactin elephant.
Urinary serotonin was positively correlated with serum prolactin concentrations in all cycling normal prolactin elephants (n = 8). Urinary serotonin concentrations ranged from a low of 21 ng/mg Crt to peak concentrations over 300 ng/mg Crt, and in one elephant over 600 ng/mg Crt.
Serum oxytocin and serotonin
Serum oxytocin concentrations increased during the follicular phase of the estrous cycle, consistent with increases in prolactin secretion ( Figure 6 ). Oxytocin increases were also occasionally observed during the luteal phase, which occurred during low prolactin periods of the estrous cycle ( Figure 6 ). Overall, serum oxytocin concentrations were low, approaching the assay sensitivity (0.0156 ng/ml) ( Table 3 ). The highest peak concentration measured at 0.34 ng/ml in one cycling elephant. Increases in serotonin concentrations were observed during both the luteal and follicular phases of the estrous cycle, similar to that observed in urine (Figure 7) . Overall, serum serotonin was easily detectible, ranging from a low of 18 ng/ml in one elephant to peak concentrations that were often over 1000 ng/ml in all elephants that were assessed. The highest peak concentration measured at 2022 ng/ml in one cycling elephant (Table 3) . 
Discussion
This is the first study to investigate the possible role of neurohormones in the etiology of hyperprolactinemia in African elephant females. Hyperprolactinemia currently impacts about 28% of the North American population and recent studies suggest it may occur in response to social stress [7] , as in other species [48] [49] [50] . In normal cycling elephants, urinary dopamine was negatively correlated, while urinary oxytocin and serotonin were positively correlated with serum prolactin concentrations as expected, suggesting these neurohormones may function in prolactin control in elephants similar to that in other species, including humans [19] . Both oxytocin and serotonin have been found to be elevated in hyperprolactinemic human patients, and we found similar results in the high prolactin elephants in this study. Thus, we propose that stimulatory factors may play a role in the observed hyperprolactinemia in this population. However, rather than being reduced as hypothesized, urinary dopamine was elevated in hyperprolactinemic elephants compared to normal and low prolactin groups. Despite its apparent lack of regulatory control over prolactin, this new evidence suggests that dopamine synthesis and secretion are not impaired in these elephants and perhaps may be augmented. Once bound to its receptor, dopamine is internalized by the lactotroph [19, 22] , where it either increases enzymatic degradation of prolactin within secretory granules or acts via autocrine-mediated mechanisms to decrease prolactin synthesis and storage when prolactin is released in conjunction with dopamine [19, 22] . Indeed, we observed that urinary dopamine concentrations were negatively correlated with serum prolactin concentrations in our normal cycling elephants, suggesting that this neurohormone may play a similar role in prolactin regulation in African elephants. Any lesion interfering with dopamine synthesis or release can increase prolactin secretion significantly, quickly, and for prolonged periods of time [13] . We therefore had hypothesized the dopamine concentrations in hyperprolactinemic elephants would be reduced compared to low prolactin or cycling elephants. The fact that we found elevated dopamine concentrations in hyperprolactinemic elephants indicates that dopamine synthesis and release are most likely not impaired in these animals. Alternatively, dopamine metabolism may be altered in these elephants so that concentrations accumulate over time rather than being renewed. Several processes terminate dopamine activity in the brain. The primary one is reuptake of dopamine back to the presynaptic neuron, facilitated via a dopamine transporter, where it is packaged into vesicles to be reused [51] . Two enzymes also metabolize dopamine both extracellularly (cathechol-O-methyltransferase) and intracellularly (monoamine oxidase) [51] . Reduction in dopamine metabolism by damage to any one of these systems could lead to an accumulation of dopamine and therefore dopamine insensitivity at the level of the lactotrophs. Finally, it is possible that dopamine's action is being interfered with either due to reduced dopamine sensitivity or as a result of vasculature isolation that prevents dopamine from reaching the lactotrophs [52, 53] , resulting in increases in circulating prolactin concentrations.
Stress can impact prolactin secretion by increasing the synthesis, secretion, and responsiveness of the organism to prolactin [48] [49] [50] . Human studies have shown that stressors, such as social conflict or academic stress, can increase the secretion of prolactin [48] [49] [50] . It is thought that dopamine may be involved in releasing prolactin from inhibition because stressors can upregulate releasing factors that contend with dopamine's inhibitory action [51] . This in turn interferes with the negative feedback loop characteristic of dopamine's control over prolactin, resulting in elevated prolactin concentrations in the face of normal or elevated dopamine secretion [13, 19, 54] . Considering that both urinary oxytocin and serotonin were elevated in the hyperprolactinemic elephants, this may be occurring in zoo elephants. Additionally, both urinary oxytocin and serotonin were positively correlated with serum prolactin concentrations in our cycling group, suggesting these neurohormones may play a similar stimulatory role in prolactin secretion to other species [22, 30-33, 35, 36] .
Oxytocin is different from most other stimulatory factors in that it appears to exert its effects directly at the level of lactotrophs [30, 31] . Hypothalamic oxytocinergic neurons terminate in the posterior pituitary and external zone of the median eminence, and once released, oxytocin is transported via portal vessels to the anterior pituitary where it binds to receptors found on lactotroph cells, inducing a release of prolactin stores [30, 31] . Additionally, oxytocin is involved in complex behaviors, such as social recognition, pair bonding, anxiety, and maternal behaviors [30, 31] . Therefore, it acts as a neuromodulator that induces or controls many physiological and behavioral effects [30, 31] . Given recent findings that hypeprolactinemia is associated with exposure to an increased number of social groups [6] , it is possible that the observed increases in urinary oxytocin and resulting hyperprolactinemia are due to behavioral compensations to social stressors.
Because prolactin is spontaneously secreted, most other stimulatory factors do not act directly on lactotrophs as oxytocin does, but rather act indirectly at the level of the hypothalamus and the TIDA system. Serotonin stimulates prolactin release from hypothalamic neurons that emanate from the raphe nucleus, and its actions are mediated via a number of serotonin receptors [34] . Serotonin appears to require an intact neurointermediate pituitary lobe to exert its stimulatory effects on prolactin, and its stimulatory role is compounded by increasing the release of other stimulatory factors [22] . Correspondingly, serotonin concentrations are increased in hyperprolactinemic patients and animal models [33, 35, 36] . This highly conserved system is also involved in the increase in prolactin secretion during stress responses in other species [34, 55, 56] . Elevated prolactin in elephants has not been linked to stress through the hypothalamo-pituitary-adrenal axis, as cortisol secretion is unaltered in hyperprolactinemic elephants [5, 6] . However, it is possible the same serotonin response system found in other species may be involved in the observed hyperprolactinemia in African elephants. Although no longer a common treatment, serotonin antagonists have been shown to reduce prolactin concentration in hyperprolactinemic subjects [33, 35, 36] and could provide an avenue for targeted treatments to treat this condition in African elephants.
If treatment with pharmaceuticals to lower prolactin concentrations (agonists or antagonists) is considered in the future, we strongly recommend that neurohormone concentrations be measured prior to the start of and throughout treatment, so that doses can be fine-tuned to individual elephants, and to better understand how treatment impacts neurohormone activity. It is also important to consider the sample type (urine vs serum) that will be used to monitor neurohormone concentrations. For example, we were unable to validate the use of serum for dopamine evaluation, although it was measurable in urine using the same assay. Furthermore, despite extraction, concentrations of oxytocin were also near the assay sensitivity in serum, but were readily detectible in urine. Perhaps dopamine and oxytocin are rapidly cleared from circulation, similar to what has been found with estradiol, where serum concentrations are low (<10 pg/ml), but urinary estrogen conjugate monitoring is a reliable method of characterizing follicular activity in elephants [5, [56] [57] [58] . In other species, including humans, saliva is increasingly used to assess hormone activity [59, 60] . Saliva contains bioactive hormones and is rapidly replacing serum for hormonal evaluations of sex steroids, adrenal function, and neurohormones in hospitals and clinics [61, 62] . Salivary cortisol has been validated and used to assess reproduction and welfare in elephants [63] [64] [65] , and may be equally useful for neurohormone determination. If so, salivary neurohormone measures could be used to examine personality differences, coping mechanisms, bonding, and sociality across age classes in elephants that are not trained for venipuncture or urine collection.
This was the first study to investigate neurohormone concentrations in both cycling and noncycling African elephants with prolactin perturbations. We were able to demonstrate that concentrations of these neurohormones in cycling elephants were similar to those found in other species. Together with the data from earlier cabergoline clinical trials, our results suggest that dopamine may be involved in prolactin regulation in African elephants; however, concentrations were increased in hyperprolactinemic elephants indicating that dopamine synthesis and release are not impaired in these individuals. It is then possible that an underlying etiology interferes with dopamine's regulatory control of prolactin, resulting in elevated circulating prolactin and dopamine concentrations. Without mitigating the underlying cause, recovery from this pituitary disorder and resumption of ovarian cyclicity is unlikely and may require long-term treatment with medication. Current research indicates that for this highly intelligent and social species, herd dynamics may play an important role in maintaining a more normal physiological state. In order to ensure a self-sustaining population, future mitigating strategies will also need to consider the social needs of elephants in human care.
